Navigation Links
U.S. Bests Canada, Europe in Drug Approvals
Date:5/16/2012

WEDNESDAY, May 16 (HealthDay News) -- New drugs are approved faster in the United States than in Europe and Canada, new research shows.

The findings counter a common belief that the drug-approval process by the U.S. Food and Drug Administration is especially slow, according to Yale University School of Medicine researchers.

The study authors reviewed drug-approval decisions made between 2001 and 2010 by the FDA, Health Canada (the Canadian drug regulator), and the European Medicines Agency (EMA). The latter agencies were chosen for comparison with the FDA because they face similar pressures to approve new drugs quickly while ensuring patient safety, the researchers said.

"Among the subsample of drugs approved for all three regulators, the FDA's reviews were over three months faster than those of the EMA or Health Canada," study leader Nicholas Downing, a second-year medical student, said in a university news release.

"The total review time at the FDA was faster than EMA, despite the FDA's far higher proportion of applications requiring multiple regulatory reviews," he added.

The study also revealed that most new drug therapies were first approved for use in the United States.

"Examining novel drugs approved in multiple markets, we found that 64 percent of medicines approved in both the U.S. and in Europe were approved for U.S. patients first, and 86 percent of medicines approved in both the U.S. and Canada were also approved first in the U.S.," Downing said.

The study was published online May 16 in the New England Journal of Medicine.

More information

The FDA explains how it approves drugs.

-- Robert Preidt

SOURCE: Yale University, news release, May 16, 2012


'/>"/>
Copyright©2010 ScoutNews,LLC.
All rights reserved  

Page: 1

Related medicine news :

1. ‘Leading' the Bestseller Race: Today We Publish —Tomorrow We Prevail!
2. Brown Rice Bests White for Diabetes Prevention
3. TAO l: The Way of All Life, by Zhi Gang Sha Reaches #6 on New York Times Bestseller List
4. Experimental Drug Bests Chemo in Non-Small Cell Lung Cancer Study
5. Grays Anatomy for Students, worlds bestselling anatomy textbooks, now available on iPad
6. Experimental Psoriasis Drug Bests Older Treatment
7. New procedure bests standard of care for fixing damaged cartilage
8. Report: For every 1 homeless person in Canada, another 23 live in inadequate housing
9. End-of-Life Care Differs Between U.S., Canada, Study Finds
10. New High Purity Immunoglobulin Enters Phase III in Europe and the US
11. Your e-Marketing Journey in 2010: An e-Book for Corporate Communicators Working in European Headquarters
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
U.S. Bests Canada, Europe in Drug Approvals
(Date:7/21/2017)... ... 21, 2017 , ... Yisrayl Hawkins, Pastor and Overseer at The House of Yahweh in Abilene, ... aggression to solve problems and pleads with world leaders to be more open about positive ... bring peace. He says there is a peaceful and positive way to solve all; yes, ...
(Date:7/21/2017)... ... July 21, 2017 , ... “Kids aren't born knowing how to regulate ... says Suzanne Tucker, Founder of St. Louis-based positive education company Generation Mindful. To help ... on Monday, July 21st. , The kit uses colorful, engaging and educational illustrations ...
(Date:7/21/2017)... ... July 21, 2017 , ... In the first prospective ... Multicenter Orthopaedics Outcome Network (MOON) demonstrated that patients could perform sports-related functions and ... levels decline over time. The study, presented today at the American Orthopaedic ...
(Date:7/20/2017)... (PRWEB) , ... July 20, 2017 , ... TransPixel Volume ... between two clips in the FCPX timeline. This effect isolates horizontal and vertical lines ... this package contains either a rotating or flipping animation and can be changed using ...
(Date:7/20/2017)... 20, 2017 (PRWEB) , ... ... ... a global provider of enterprise-grade IT operations analytics and application performance monitoring ... one of world’s largest healthcare services providers. , According to Peter Ohrenberger, ...
Breaking Medicine News(10 mins):
(Date:7/21/2017)... RESEARCH TRIANGLE PARK, N.C. , July ... UTHR ) announced today that it will report ... opens on Thursday, July 27, 2017. ... on Thursday, July 27, 2017, at 9:00 a.m. Eastern ... international callers dialing 1-970-315-0533.  A rebroadcast of the teleconference ...
(Date:7/20/2017)... -- Prime Therapeutics LLC (Prime) released this statement from its Chief ... for Clinical and Economic Review,s (ICER) public meeting ... of abuse-deterrent formulations (ADF) of opioids. Prime was the sole ... "The ICER data ... use of abuse-deterrent formulations (ADF) in opioids in terms of ...
(Date:7/15/2017)... Enterin Inc., a Philadelphia -based ... today announced the completion of a $12.7 million Series A ... as well as the participation of existing investors. ... the support of New Ventures III and our current investors, ... the potential of our platform technology to transform the course ...
Breaking Medicine Technology: